Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 4
1990 11
1991 1
1992 7
1993 8
1994 8
1995 5
1996 10
1997 14
1998 18
1999 19
2000 23
2001 15
2002 19
2003 13
2004 9
2005 6
2006 7
2007 6
2008 3
2009 3
2010 8
2011 7
2012 6
2013 5
2014 9
2015 16
2016 12
2017 16
2018 12
2019 7
2020 14
2021 15
2022 6
2023 7
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators. Hadoux J, et al. N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870969 Clinical Trial.
Pituitary Autoimmunity.
Guaraldi F, Giordano R, Grottoli S, Ghizzoni L, Arvat E, Ghigo E. Guaraldi F, et al. Among authors: arvat e. Front Horm Res. 2017;48:48-68. doi: 10.1159/000452905. Epub 2017 Feb 28. Front Horm Res. 2017. PMID: 28245451 Review.
8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2).
Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, Bellantone R, Pontecorvi A, Montesano T, Pagano L, Daniele L, Fugazzola L, Ceresini G, Bruno R, Rossetto R, Tumino S, Centanni M, Meringolo D, Castagna MG, Salvatore D, Nicolucci A, Lucisano G, Filetti S, Durante C. Lamartina L, et al. Among authors: arvat e. Endocr Relat Cancer. 2018 Mar;25(3):L7-L11. doi: 10.1530/ERC-17-0453. Epub 2017 Nov 30. Endocr Relat Cancer. 2018. PMID: 29192093 Free article. No abstract available.
Diagnostic work-up in steroid myopathy.
Minetto MA, D'Angelo V, Arvat E, Kesari S. Minetto MA, et al. Among authors: arvat e. Endocrine. 2018 May;60(2):219-223. doi: 10.1007/s12020-017-1472-5. Epub 2017 Nov 15. Endocrine. 2018. PMID: 29143179 Review.
Growth hormone-releasing peptides.
Ghigo E, Arvat E, Muccioli G, Camanni F. Ghigo E, et al. Among authors: arvat e. Eur J Endocrinol. 1997 May;136(5):445-60. doi: 10.1530/eje.0.1360445. Eur J Endocrinol. 1997. PMID: 9186261 Review.
Endocrine Autoimmunity in Down's Syndrome.
Guaraldi F, Rossetto Giaccherino R, Lanfranco F, Motta G, Gori D, Arvat E, Ghigo E, Giordano R. Guaraldi F, et al. Among authors: arvat e. Front Horm Res. 2017;48:133-146. doi: 10.1159/000452912. Epub 2017 Feb 28. Front Horm Res. 2017. PMID: 28245458 Review.
Steroid myopathy: some unresolved issues.
Minetto MA, Lanfranco F, Motta G, Allasia S, Arvat E, D'Antona G. Minetto MA, et al. Among authors: arvat e. J Endocrinol Invest. 2011 May;34(5):370-5. doi: 10.1007/BF03347462. J Endocrinol Invest. 2011. PMID: 21677507 Review.
Diabetes in Cancer Patients: Risks, Goals and Management.
Ragni A, Retta F, Arvat E, Gallo M. Ragni A, et al. Among authors: arvat e. Front Horm Res. 2021;54:103-114. doi: 10.1159/000513807. Epub 2021 Feb 8. Front Horm Res. 2021. PMID: 33556942 Review.
327 results